Comprehensive Genetic Testing of CYP21A2 : A Retrospective Analysis in Patients with Suspected Congenital Adrenal Hyperplasia

• Published in: Journal of clinical medicine Vol. 10; no. 6; p. 1183
• Main Authors: Nan, Madalina Nicoleta, Roig, Rosa, Martínez, Susana, Rives, Jose, Urgell, Eulàlia, Espinós, Juan José, Tirado, Mireia, Carreras, Gemma, Aulinas, Anna, Webb, Susan M, Corcoy, Rosa, Blanco-Vaca, Francisco, Tondo, Mireia
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 12-03-2021; MDPI
• Subjects: Acne; Bioinformatics; Clinical medicine; Enzymes; Genetic counseling; Genotype & phenotype; Hyperplasia; Infertility; Menstruation; Mutation; Patients; Population; Software; Variables; United States > US; genotype analysis; 17-OH progesterone; CYP21A2 gene; congenital adrenal hyperplasia; genotype-phenotype correlation
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm10061183

The most common form of congenital adrenal hyperplasia (CAH) results from a deficiency of the 21-hydroxylase enzyme (21-OHD), presenting with a broad spectrum of clinical phenotypes according to the
gene mutations. Of the 59 patients with suspected CAH, 62.7% presented a positive genetic result. Of them, 78.4% and 18.9% presented with non-classical and classical forms, respectively. An overall phenotype-genotype correlation of 88.9% was observed. Biochemically, 17-hydroxiprogesterone concentrations were significantly higher in genetically confirmed patients. Genetically, 36 patients presented with previously reported pathogenic variants, and one presented a new variant in homozygosis. Among the 74 alleles tested, point mutations were found in 89.2% and large rearrangements were found in the rest. The most prevalent pathogenic variant was p.(Val282Leu). The inclusion of relatives revealed one further case. Interestingly, 87.5% of relatives were carriers of a pathogenic variant, including two siblings initially classified as genetically positive. In addition, the study of male partners with gestational desire identified several carriers of mild mutations. Studying the allelic distribution of the variants also allowed for reclassifying one patient. In conclusion, a genetic approach including Sanger sequencing, multiplex ligation-dependent probe amplification (MLPA) analysis, and allelic distribution of the pathogenic variants represents a beneficial tool for better classifying patients with 21-OHD.